How was your experience today? The value of this radio input is:Awful The value of this radio input is:Bad The value of this radio input is:OK The value of this radio input is:Good The value of this radio input is:Great Send feedback ...
Journal Impact Factor: 2.9 5-year Journal Impact Factor: 3.3 Source Normalized Impact per Paper (SNIP): 0.775 SCImago Journal Rank (SJR): 0.815 Speed 2023 Submission to first editorial decision (median days): 14 Submission to acceptance (median days): 188 ...
Our team is always growing, so join us and start making your impact today. Search jobs Business development & licensing We follow the science where we can make the greatest difference, now and in the future. We’ve made significant investments over the past few years in immunology through ...
Immunosuppressive side effects of chemotherapeutics. Several of the cancer chemotherapeutics that are used today are also used as immunosuppressants for the treatment of severe systemic autoimmune diseases. This applies to cyclophosphamide5and methotrexate6(Box 1), which impair the proliferative and/or eff...
How was your experience today? The value of this radio input is:Awful The value of this radio input is:Bad The value of this radio input is:OK The value of this radio input is:Good The value of this radio input is:Great Send feedback ...
Journal Impact Factor: 2.6 5-year Journal Impact Factor: 3.5 Source Normalized Impact per Paper (SNIP): 0.904 SCImago Journal Rank (SJR): 0.749Speed 2023 Submission to first editorial decision (median days): 18 Submission to acceptance (median days): 140Usage 2023 Downloads: 1,545,686 Altmet...
Share your knowledge, influence clinical practices and enhance patient care in Immunology today! Peer-reviewed, free-to-access Accepting reviews, research and editorials No article processing fees Digital features and plain language summaries Multichannel content distribution for maximum visibility ...
ceruloplasmin and complement factor B. At the same time, the production of other factors, such as albumin, transferrin, fibronectin, a-fetoprotein and complement factor 3, is reduced [149,150,151,152,153]. APPs strongly impact systemic inflammation and pathogen clearance. APPs act through a wide...
ceruloplasmin and complement factor B. At the same time, the production of other factors, such as albumin, transferrin, fibronectin, a-fetoprotein and complement factor 3, is reduced [149,150,151,152,153]. APPs strongly impact systemic inflammation and pathogen clearance. APPs act through a wide...
(Figure 17.4), but most profound may be their ability to predict risk, track disease progression and anticipate clinical events, thereby enabling truly personalized, predictive, preventative care. To do this, the strengths of today's disease-oriented reductionist approach must be integrated with an...